Trial Profile
A Retrospective Study Assessing Outcome of Everolimus Based Therapy in Hormone Receptor Positive Metastatic Breast Cancer Patients after Progression on Palbociclib Combination
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 18 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.